In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gillette

This article was originally published in The Rose Sheet

Executive Summary

Massachusetts Secretary of the Commonwealth William Galvin subpoena Gillette President & CEO James Kilts to testify June 1 regarding fairness opinions generated by Goldman, Sachs & Co. and UBS Securities in connection with the firm's acquisition by Procter & Gamble. Galvin also issues May 19 subpoenas al testificandum to Goldman Sachs employees Jack Levy and Stephan Feldgoise and UBS Securities' Richard Case and Blair Effron relating to fairness opinions provided by the firms. Galvin previously issued subpoenaes to Gillette employees in connection with the acquisition, which he has been investigating since February (1"The Rose Sheet" May 16, 2005, In Brief and 2"The Rose Sheet" Feb. 7, 2005, p. 8)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013083

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel